Cargando…

Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial

Antibodies (Abs) specific for CD4-induced envelope (Env) epitopes within constant region 1 and 2 (C1/C2) were induced in the RV144 vaccine trial, where antibody-dependent cellular cytotoxicity (ADCC) correlated with reduced risk of HIV-1 infection. We combined X-ray crystallography and fluorescence...

Descripción completa

Detalles Bibliográficos
Autores principales: Tolbert, William D., Van, Verna, Sherburn, Rebekah, Tuyishime, Marina, Yan, Fang, Nguyen, Dung N., Stanfield-Oakley, Sherry, Easterhoff, David, Bonsignori, Mattia, Haynes, Barton F., Moody, M. Anthony, Ray, Krishanu, Ferrari, Guido, Lewis, George K., Pazgier, Marzena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327165/
https://www.ncbi.nlm.nih.gov/pubmed/32605979
http://dx.doi.org/10.1128/mBio.00208-20
_version_ 1783552485818892288
author Tolbert, William D.
Van, Verna
Sherburn, Rebekah
Tuyishime, Marina
Yan, Fang
Nguyen, Dung N.
Stanfield-Oakley, Sherry
Easterhoff, David
Bonsignori, Mattia
Haynes, Barton F.
Moody, M. Anthony
Ray, Krishanu
Ferrari, Guido
Lewis, George K.
Pazgier, Marzena
author_facet Tolbert, William D.
Van, Verna
Sherburn, Rebekah
Tuyishime, Marina
Yan, Fang
Nguyen, Dung N.
Stanfield-Oakley, Sherry
Easterhoff, David
Bonsignori, Mattia
Haynes, Barton F.
Moody, M. Anthony
Ray, Krishanu
Ferrari, Guido
Lewis, George K.
Pazgier, Marzena
author_sort Tolbert, William D.
collection PubMed
description Antibodies (Abs) specific for CD4-induced envelope (Env) epitopes within constant region 1 and 2 (C1/C2) were induced in the RV144 vaccine trial, where antibody-dependent cellular cytotoxicity (ADCC) correlated with reduced risk of HIV-1 infection. We combined X-ray crystallography and fluorescence resonance energy transfer-fluorescence correlation spectroscopy to describe the molecular basis for epitopes of seven RV144 Abs and compared them to A32 and C11, C1/C2 Abs induced in HIV infection. Our data indicate that most vaccine Abs recognize the 7-stranded β-sandwich of gp120, a unique hybrid epitope bridging A32 and C11 binding sites. Although primarily directed at the 7-stranded β-sandwich, some accommodate the gp120 N terminus in C11-bound 8-stranded conformation and therefore recognize a broader range of CD4-triggered Env conformations. Our data also suggest that Abs of RV144 and RV305, the RV144 follow-up study, although likely initially induced by the ALVAC-HIV prime encoding full-length gp120, matured through boosting with truncated AIDSVAX gp120 variants.
format Online
Article
Text
id pubmed-7327165
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-73271652020-07-01 Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial Tolbert, William D. Van, Verna Sherburn, Rebekah Tuyishime, Marina Yan, Fang Nguyen, Dung N. Stanfield-Oakley, Sherry Easterhoff, David Bonsignori, Mattia Haynes, Barton F. Moody, M. Anthony Ray, Krishanu Ferrari, Guido Lewis, George K. Pazgier, Marzena mBio Research Article Antibodies (Abs) specific for CD4-induced envelope (Env) epitopes within constant region 1 and 2 (C1/C2) were induced in the RV144 vaccine trial, where antibody-dependent cellular cytotoxicity (ADCC) correlated with reduced risk of HIV-1 infection. We combined X-ray crystallography and fluorescence resonance energy transfer-fluorescence correlation spectroscopy to describe the molecular basis for epitopes of seven RV144 Abs and compared them to A32 and C11, C1/C2 Abs induced in HIV infection. Our data indicate that most vaccine Abs recognize the 7-stranded β-sandwich of gp120, a unique hybrid epitope bridging A32 and C11 binding sites. Although primarily directed at the 7-stranded β-sandwich, some accommodate the gp120 N terminus in C11-bound 8-stranded conformation and therefore recognize a broader range of CD4-triggered Env conformations. Our data also suggest that Abs of RV144 and RV305, the RV144 follow-up study, although likely initially induced by the ALVAC-HIV prime encoding full-length gp120, matured through boosting with truncated AIDSVAX gp120 variants. American Society for Microbiology 2020-06-30 /pmc/articles/PMC7327165/ /pubmed/32605979 http://dx.doi.org/10.1128/mBio.00208-20 Text en Copyright © 2020 Tolbert et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Tolbert, William D.
Van, Verna
Sherburn, Rebekah
Tuyishime, Marina
Yan, Fang
Nguyen, Dung N.
Stanfield-Oakley, Sherry
Easterhoff, David
Bonsignori, Mattia
Haynes, Barton F.
Moody, M. Anthony
Ray, Krishanu
Ferrari, Guido
Lewis, George K.
Pazgier, Marzena
Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial
title Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial
title_full Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial
title_fullStr Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial
title_full_unstemmed Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial
title_short Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial
title_sort recognition patterns of the c1/c2 epitopes involved in fc-mediated response in hiv-1 natural infection and the rv114 vaccine trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327165/
https://www.ncbi.nlm.nih.gov/pubmed/32605979
http://dx.doi.org/10.1128/mBio.00208-20
work_keys_str_mv AT tolbertwilliamd recognitionpatternsofthec1c2epitopesinvolvedinfcmediatedresponseinhiv1naturalinfectionandtherv114vaccinetrial
AT vanverna recognitionpatternsofthec1c2epitopesinvolvedinfcmediatedresponseinhiv1naturalinfectionandtherv114vaccinetrial
AT sherburnrebekah recognitionpatternsofthec1c2epitopesinvolvedinfcmediatedresponseinhiv1naturalinfectionandtherv114vaccinetrial
AT tuyishimemarina recognitionpatternsofthec1c2epitopesinvolvedinfcmediatedresponseinhiv1naturalinfectionandtherv114vaccinetrial
AT yanfang recognitionpatternsofthec1c2epitopesinvolvedinfcmediatedresponseinhiv1naturalinfectionandtherv114vaccinetrial
AT nguyendungn recognitionpatternsofthec1c2epitopesinvolvedinfcmediatedresponseinhiv1naturalinfectionandtherv114vaccinetrial
AT stanfieldoakleysherry recognitionpatternsofthec1c2epitopesinvolvedinfcmediatedresponseinhiv1naturalinfectionandtherv114vaccinetrial
AT easterhoffdavid recognitionpatternsofthec1c2epitopesinvolvedinfcmediatedresponseinhiv1naturalinfectionandtherv114vaccinetrial
AT bonsignorimattia recognitionpatternsofthec1c2epitopesinvolvedinfcmediatedresponseinhiv1naturalinfectionandtherv114vaccinetrial
AT haynesbartonf recognitionpatternsofthec1c2epitopesinvolvedinfcmediatedresponseinhiv1naturalinfectionandtherv114vaccinetrial
AT moodymanthony recognitionpatternsofthec1c2epitopesinvolvedinfcmediatedresponseinhiv1naturalinfectionandtherv114vaccinetrial
AT raykrishanu recognitionpatternsofthec1c2epitopesinvolvedinfcmediatedresponseinhiv1naturalinfectionandtherv114vaccinetrial
AT ferrariguido recognitionpatternsofthec1c2epitopesinvolvedinfcmediatedresponseinhiv1naturalinfectionandtherv114vaccinetrial
AT lewisgeorgek recognitionpatternsofthec1c2epitopesinvolvedinfcmediatedresponseinhiv1naturalinfectionandtherv114vaccinetrial
AT pazgiermarzena recognitionpatternsofthec1c2epitopesinvolvedinfcmediatedresponseinhiv1naturalinfectionandtherv114vaccinetrial